spacer
home > ict > autumn 2018 > talking travel
PUBLICATIONS
International Clinical Trials

Talking Travel

Patient Engagement Demands

Two major factors have been, and continue to be, prime movers in the area of patient engagement: the ever- and exponentially increasing competition for eligible and interested patients and the burgeoning and rapidly evolving internet-driven service industry, which is often experienced by users through the utilisation of mobile device applications. The collision of the two – specifically, the sheer volume of the one and the culture of immediacy and convenience of the other – quickly set expectations exceptionally high for rapid results, which have been felt by sponsor clinical teams and service providers alike.

Undeniable Positive Impact

The following are three representative case studies, showing different travel solutions and retention challenges:

Superior retention of those using the service in this study scenario makes sense. When mobility problems and significant distances from the sites are concerning, one would expect a professional travel assistance programme to remove a major barrier to participation. However, what about when the travel distance is not great and the patients are relatively self-sufficient with no mobility issues? Is there really such a big difference?

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Hannu Koski at BBK Worldwide specialises in strategic services and manages all research and analytics initiatives for the organisation. He is committed to incorporating both patient and clinical team voices to improve end-user satisfaction, enhance patient engagement and retention, and accelerate development and implementation deadlines. Hannu holds a Master’s degree in economics and business administration from the University of Oulu, Finland.

Rob Laurens has been with BBK Worldwide for more than 24 years. In that time, he has contributed not only to the success of many campaigns, but also to furthering the industry’s understanding and value of both patient recruitment and patient centricity. With an expansive background in creative direction, strategy, and copywriting, as well as sponsor consultation, Rob directs BBK’s internal professional development commitment. Rob also leads BBK’s Quality Assurance team.
spacer
Hannu Koski
spacer
spacer
spacer
Rob Laurens
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

White Papers
 
Industry Events

Clinical Innovation Partnerships

11-12 September 2019, Hotel Palace, Berlin

Clinical Innovation Partnerships is the only event for senior clinical operations and procurement professionals driving innovation in their clinical trials. It is where the pharma, CRO and vendor clinical trials ecosystem meet to drive innovation in digitalisation, tech and partnering to improve patient experience and reduce trial cost and time.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement